Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Meta-Analysis

Association Between Heart Rate Variability and Parkinson’s Disease: A Meta-analysis

Author(s): Yuan Li, Junjie Wang, Xinyi Li, Wei Jing*, Itohan Omorodion and Lei Liu

Volume 27, Issue 17, 2021

Published on: 05 September, 2020

Page: [2056 - 2067] Pages: 12

DOI: 10.2174/1871527319666200905122222

Price: $65

Abstract

Aim: A systematic review which aims to assess the evidence regarding the function of the autonomic heart rate regulation system among Parkinson’s disease (PD) patients. The main objective of the study is to compare heart rate variability (HRV) between those with and without PD from published studies. The subgroup analyses aimed to investigate the impact of treatment and disease duration on heart rate variability (HRV), assessed by measuring sympathetic and parasympathetic activity via low-frequency (LF) and high-frequency (HF) power spectrum scores, in patients with Parkinson’s disease (PD).

Methods: PubMed, Cochrane Library, Embase and Web of Science were searched using the keywords “Parkinson’s disease” and “heart rate variability”. Studies that reported at least one HRV variable were included. The quality of the included studies was evaluated, and the relevant information was extracted. A meta-analysis was carried out with Stata software. We followed the PRISMA guidelines for all stages of the meta-analysis. PROSPERO registration number: CRD42021242766.

Results: Thirteen references (16 studies) were included in our analysis. The LF values (g -0.27; 95% confidence interval (CI) -0.53 to -0.01) of the patients with PD were lower than the controls. No significant differences in HF values (g -0.11; 95% CI -0.28 to 0.06) were observed between groups. Subgroup analyses of HRV outcomes in patients stratified by treatment status and disease duration were performed. For LF, patients with a disease duration of less than 5 years presented lower HF (g -0.25; 95% CI -0.44 to -0.06) values than controls. Regarding HF, patients receiving treatment presented lower HF (g -0.22; 95% CI -0.40 to 0.05) values than controls, and patients with a disease duration greater than 5 years also presented lower HF (g -0.29; 95% CI -0.56 to -0.03) values than controls.

Discussion: We have confirmed and elaborated on the hypothesis of sympathovagal imbalance in PD. Knowledge of the effect of sympathovagal balance on HRV may inform the design of therapeutic regimens for PD. However, between-study heterogeneity and methodological issues limit the generalizability of the evidence; thus, future studies employing strict methodologies are warranted.

Conclusion: Our meta-analysis found that PD is associated with reduced HRV values, which indicates that both sympathetic and vagal activities are decreased. Patients in the early stage of PD have sympathetic autonomic nerve dysfunction, with only minor damage to sympathetic activity.

Keywords: Parkinson's disease, heart rate variability, meta-analysis, HRV variable, HF values, HRV outcomes.

« Previous Next »
[1]
Chen Z, Li G, Liu J. Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment. Neurobiol Dis 2020; 134(2)104700
[http://dx.doi.org/10.1016/j.nbd.2019.104700] [PMID: 31809788]
[2]
Jost WH. Autonomic dysfunction in Parkinson’s disease: cardiovascular symptoms, thermoregulation, and urogenital symptoms. Int Rev Neurobiol 2017; 134(11): 771-85.
[http://dx.doi.org/10.1016/bs.irn.2017.04.003] [PMID: 28805582]
[3]
Galvin JE, Lee VM, Trojanowski JQ. Synucleinopathies: clinical and pathological implications. Arch Neurol 2001; 58(2): 186-90.
[http://dx.doi.org/10.1001/archneur.58.2.186] [PMID: 11176955]
[4]
Djaldetti R, Lev N, Melamed E. Lesions outside the CNS in Parkinson’s disease. Mov Disord 2009; 24(6): 793-800.
[http://dx.doi.org/10.1002/mds.22172] [PMID: 19224610]
[5]
Buob A, Winter H, Kindermann M, et al. Parasympathetic but not sympathetic cardiac dysfunction at early stages of Parkinson’s disease. Clin Res Cardiol 2010; 99(11): 701-6.
[http://dx.doi.org/10.1007/s00392-010-0170-6] [PMID: 20443012]
[6]
Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N. Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson’s disease. J Neurol Sci 2009; 276(1-2): 79-83.
[http://dx.doi.org/10.1016/j.jns.2008.09.005] [PMID: 18838148]
[7]
Li K, Haase R, Rüdiger H, et al. Subthalamic nucleus stimulation and levodopa modulate cardiovascular autonomic function in Parkinson’s disease. Sci Rep 2017; 7(1): 7012.
[http://dx.doi.org/10.1038/s41598-017-07429-9] [PMID: 28765629]
[8]
Chung CY, Koprich JB, Hallett PJ, Isacson O. Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proc Natl Acad Sci USA 2009; 106(52): 22474-9.
[http://dx.doi.org/10.1073/pnas.0912193106] [PMID: 20007772]
[9]
Listed NA. Heart rate variability standards of measurement, physiological interpretation, and clinical use. Quintessence Editora 1996; 80(3): 204-16.
[10]
Karemaker JM. Autonomic integration: the physiological basis of cardiovascular variability. J Physiol 1999; 517(Pt 2): 316-29.
[http://dx.doi.org/10.1111/j.1469-7793.1999.0316t.x] [PMID: 10332083]
[11]
Faurholt-Jepsen M, Kessing LV, Munkholm K. Heart rate variability in bipolar disorder: A systematic review and meta-analysis. Neurosci Biobehav Rev 2017; 73(3): 68-80.
[http://dx.doi.org/10.1016/j.neubiorev.2016.12.007] [PMID: 27986468]
[12]
Haapaniemi TH, Pursiainen V, Korpelainen JT, Huikuri HV, Sotaniemi KA, Myllylä VV. Ambulatory ECG and analysis of heart rate variability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2001; 70(3): 305-10.
[http://dx.doi.org/10.1136/jnnp.70.3.305] [PMID: 11181850]
[13]
Devos D, Kroumova M, Bordet R, et al. Heart rate variability and Parkinson’s disease severity. J Neural Transm (Vienna) 2003; 110(9): 997-1011.
[http://dx.doi.org/10.1007/s00702-003-0016-8] [PMID: 12928836]
[14]
Bouhaddi M, Vuillier F, Fortrat JO, et al. Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson’s disease: involvement of L-dopa therapy. Auton Neurosci 2004; 116(1-2): 30-8.
[http://dx.doi.org/10.1016/j.autneu.2004.06.009] [PMID: 15556835]
[15]
Barbic F, Perego F, Canesi M, et al. Early abnormalities of vascular and cardiac autonomic control in Parkinson’s disease without orthostatic hypotension. Hypertension 2007; 49(1): 120-6.
[http://dx.doi.org/10.1161/01.HYP.0000250939.71343.7c] [PMID: 17101845]
[16]
Allan LM, Ballard CG, Allen J, et al. Autonomic dysfunction in dementia. J Neurol Neurosurg Psychiatry 2007; 78(7): 671-7.
[http://dx.doi.org/10.1136/jnnp.2006.102343] [PMID: 17178816]
[17]
Niwa F, Kuriyama N, Nakagawa M, Imanishi J. Circadian rhythm of rest activity and autonomic nervous system activity at different stages in Parkinson’s disease. Auton Neurosci 2011; 165(2): 195-200.
[http://dx.doi.org/10.1016/j.autneu.2011.07.010] [PMID: 21871844]
[18]
Sriranjini SJ, Ganesan M, Datta K, Pal PK, Sathyaprabha TN. Effect of a single dose of standard levodopa on cardiac autonomic function in Parkinson’s disease. Neurol India 2011; 59(5): 659-63.
[http://dx.doi.org/10.4103/0028-3886.86536] [PMID: 22019646]
[19]
Brown R, Duma S, Piguet O, Broe GA, Macefield VG. Cardiovascular variability in Parkinson’s disease and extrapyramidal motor slowing. Clin Auton Res 2012; 22(4): 191-6.
[http://dx.doi.org/10.1007/s10286-012-0163-9] [PMID: 22532273]
[20]
Liou LM, Ruge D, Chang YP, et al. Functional connectivity between lateral premotor-parietal circuits and the cardiac autonomic system in Parkinson’s disease. J Neurol Sci 2013; 326(1-2): 48-52.
[http://dx.doi.org/10.1016/j.jns.2013.01.008] [PMID: 23375958]
[21]
Asahina M, Mathias CJ, Katagiri A, et al. Sudomotor and cardiovascular dysfunction in patients with early untreated Parkinson’s disease. J Parkinsons Dis 2014; 4(3): 385-93.
[http://dx.doi.org/10.3233/JPD-130326] [PMID: 24577504]
[22]
Rocha RSB, De Oliveira Rocha LS, Pena ESM, Caldas LCP, Moreno MA. Analysis of autonomic modulation of heart rate in patients with Parkinson’s disease and elderly individuals submitted to game therapy training. Geriatr Gerontol Int 2018; 18(1): 20-5.
[http://dx.doi.org/10.1111/ggi.13130] [PMID: 28836338]
[23]
Visanji NP, Bhudhikanok GS, Mestre TA, et al. Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson’s disease. Mov Disord 2017; 32(4): 610-4.
[http://dx.doi.org/10.1002/mds.26896] [PMID: 28071824]
[24]
Rocchi C, Placidi F, Liguori C, et al. Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study. Sleep Med 2018; 52(4): 163-7.
[http://dx.doi.org/10.1016/j.sleep.2018.08.023] [PMID: 30359891]
[25]
Antelmi I, de Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol 2004; 93(3): 381-5.
[http://dx.doi.org/10.1016/j.amjcard.2003.09.065] [PMID: 14759400]
[26]
Koenig J, Thayer JF. Sex differences in healthy human heart rate variability: A meta-analysis. Neurosci Biobehav Rev 2016; 64(7): 288-310.
[http://dx.doi.org/10.1016/j.neubiorev.2016.03.007] [PMID: 26964804]
[27]
Jellinger KA. Post mortem studies in Parkinson’s disease--is it possible to detect brain areas for specific symptoms? J Neural Transm Suppl 1999; 56(Suppl.): 1-29.
[http://dx.doi.org/10.1007/978-3-7091-6360-3_1] [PMID: 10370901]
[28]
Alonso A, Huang X, Mosley TH, Heiss G, Chen H. Heart rate variability and the risk of Parkinson disease: The Atherosclerosis Risk in Communities study. Ann Neurol 2015; 77(5): 877-83.
[http://dx.doi.org/10.1002/ana.24393] [PMID: 25707861]
[29]
Valappil RA, Black JE, Broderick MJ, et al. Exploring the electrocardiogram as a potential tool to screen for premotor Parkinson’s disease. Mov Disord 2010; 25(14): 2296-303.
[http://dx.doi.org/10.1002/mds.23348] [PMID: 20976736]
[30]
Holmberg B, Kallio M, Johnels B, Elam M. Cardiovascular reflex testing contributes to clinical evaluation and differential diagnosis of Parkinsonian syndromes. Mov Disord 2001; 16(2): 217-25.
[http://dx.doi.org/10.1002/mds.1062] [PMID: 11295773]

Rights & Permissions Print Cite
Article Metrics
39
1
© 2024 Bentham Science Publishers | Privacy Policy